钆塞酸二钠MRI评估肝细胞癌对钇-90放射性栓塞治疗的反应:与组织病理学对照
回顾性纳入48例经TARE治疗后手术的HCC患者,用钆塞酸二钠MRI在术前90天内评估肿瘤反应;减影图像上坏死百分比和EASL标准是CPN的独立预测因子,减影、mRECIST、EASL和LI-RADS-TR诊断CPN的AUC为0.78-0.83,影像坏死百分比与病理坏死程度显著相关(r=0.66-0.8,P<0.001)。
要点
- 减影图像上坏死百分比和EASL标准是TARE治疗后HCC完全病理坏死的独立预测因子。
- 减影、mRECIST、EASL和LI-RADS-TR诊断CPN的AUC为0.78-0.83,减影与LI-RADS-TR在读者2的AUC差异显著。
- 影像坏死百分比与病理坏死程度显著相关(r=0.66-0.8,P<0.001),减影可用于评估TARE反应。
核心结论
- 减影图像上肿瘤坏死百分比和EASL标准是TARE治疗后HCC完全病理坏死的显著独立预测因子,使用MRI评估HCC对TARE的反应时应考虑图像减影。
研究设计与样本
- 回顾性研究,纳入48例(男36例、女12例,平均年龄62岁)TARE治疗后手术的HCC患者,手术前90天内行钆塞酸二钠MRI;两名放射科医生采用RECIST1.1、mRECIST、EASL和LI-RADS-TR标准评估肿瘤反应,并在减影图像的晚动脉期、门静脉期和肝胆期评估坏死百分比;以组织病理学为参考标准。
诊断标准与关键数值
- 组织病理学显示71个HCC(大小2.8±1.7 cm,范围0.5-7.5 cm),其中42个完全病理坏死、22个部分坏死、7个无坏死;EASL标准和减影图像上晚动脉期/门静脉期肿瘤坏死百分比是CPN的独立预测因子(P=0.02-0.03);坏死百分比、mRECIST、EASL和LI-RADS-TR诊断CPN的AUC为0.78-0.83,读者2的减影与LI-RADS-TR之间AUC差异显著,两名读者的减影与其他标准之间特异度差异显著(P范围0.01-0.04);影像坏死百分比与组织病理学肿瘤坏死程度显著相关(r=0.66-0.8,P<0.001)。
临床应用与阅片要点
- 使用钆塞酸二钠MRI评估HCC对TARE的反应时,可考虑采用图像减影评估肿瘤坏死百分比,并结合EASL标准预测完全病理坏死。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND AIMS: Transarterial 90Y radioembolization (TARE) is increasingly being used for hepatocellular carcinoma (HCC) treatment. However, tumor response assessment after TARE may be challenging. We aimed to assess the diagnostic performance of gadoxetate disodium MRI for predicting complete pathologic necrosis (CPN) of HCC treated with TARE, using histopathology as the reference standard.
METHODS: This retrospective study included 48 patients (M/F: 36/12, mean age: 62 years) with HCC treated by TARE followed by surgery with gadoxetate disodium MRI within 90 days of surgery. Two radiologists evaluated tumor response using RECIST1.1, mRECIST, EASL, and LI-RADS-TR criteria and evaluated the percentage of necrosis on subtraction during late arterial, portal venous, and hepatobiliary phases (AP/PVP/HBP). Statistical analysis included inter-reader agreement, correlation between radiologic and pathologic percentage of necrosis, and prediction of CPN using logistic regression and ROC analyses.
RESULTS: Histopathology demonstrated 71 HCCs (2.8 ± 1.7 cm, range: 0.5-7.5 cm) including 42 with CPN, 22 with partial necrosis, and 7 without necrosis. EASL and percentage of tumor necrosis on subtraction at the AP/PVP were independent predictors of CPN (p = 0.02-0.03). Percentage of necrosis, mRECIST, EASL, and LI-RADS-TR had fair to good performance for diagnosing CPN (AUCs: 0.78 - 0.83), with a significant difference between subtraction and LI-RADS-TR for reader 2, and in specificity between subtraction and other criteria for both readers (p-range: 0.01-0.04). Radiologic percentage of necrosis was significantly correlated to histopathologic degree of tumor necrosis (r = 0.66 - 0.8, p < 0.001).
CONCLUSIONS: Percentage of tumor necrosis on subtraction and EASL criteria were significant independent predictors of CPN in HCC treated with TARE. Image subtraction should be considered for assessing HCC response to TARE when using MRI.
KEY POINTS: • Percentage of tumor necrosis on image subtraction and EASL criteria are significant independent predictors of complete pathologic necrosis in hepatocellular carcinoma treated with90Y radioembolization. • Subtraction, mRECIST, EASL, and LI-RADS-TR have fair to good performance for diagnosing complete pathologic necrosis in hepatocellular carcinoma treated with90Y radioembolization.
引用
- Vietti Violi, Gnerre, Law, et al. Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology. Eur Radiol. 2022. PMID: 35380226. doi:10.1007/s00330-022-08732-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。